CNR1 and Hepatitis: In addition, while the activation of the CB1R with an agonist promoted the expression and activation of the NLRP3 inflammasome in Kupffer cells, blocking CB1R with the antagonist AM281 reduced the expression of NLRP3, inflammasome activation, and liver inflammation [62].